North America Drugs for Malaria Market by Manufacturers, Countries, Type and Application, Forecast to 2022

1 Market Overview

1.1 Drugs for Malaria Introduction

1.2 Market Analysis by Type

1.2.1 Aryl Aminoalcohol Compounds

1.2.2 Antifolate Compounds

1.2.3 Artemisinin Compounds

1.3 Market Analysis by Applications

1.3.1 Prevention

1.3.2 Treatment

1.3.3 Other

1.4 Market Analysis by Countries

1.4.1 United States Status and Prospect (2012-2022)

1.4.2 Mexico Status and Prospect (2012-2022)

1.4.3 Canada Status and Prospect (2012-2022)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Cipla

2.1.1 Profile

2.1.2 Drugs for Malaria Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.4 Business Overview

2.1.5 Cipla News

2.2 Guilin Pharmaceutical

2.2.1 Profile

2.2.2 Drugs for Malaria Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.4 Business Overview

2.2.5 Guilin Pharmaceutical News

2.3 IPCA Laboratories

2.3.1 Profile

2.3.2 Drugs for Malaria Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.4 Business Overview

2.3.5 IPCA Laboratories News

2.4 GlaxoSmithKline

2.4.1 Profile

2.4.2 Drugs for Malaria Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.4 Business Overview

2.4.5 GlaxoSmithKline News

2.5 Mylan Labs

2.5.1 Profile

2.5.2 Drugs for Malaria Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.4 Business Overview

2.5.5 Mylan Labs News

2.6 Roche

2.6.1 Profile

2.6.2 Drugs for Malaria Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.4 Business Overview

2.6.5 Roche News

2.7 Novartis

2.7.1 Profile

2.7.2 Drugs for Malaria Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.4 Business Overview

2.7.5 Novartis News

2.8 Sanofi Aventis

2.8.1 Profile

2.8.2 Drugs for Malaria Type and Applications

2.8.2.1 Type 1

2.8.2.2 Type 2

2.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8.4 Business Overview

2.8.5 Sanofi Aventis News

2.9 Ajanta Pharma

2.9.1 Profile

2.9.2 Drugs for Malaria Type and Applications

2.9.2.1 Type 1

2.9.2.2 Type 2

2.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9.4 Business Overview

2.9.5 Ajanta Pharma News

3 North America Drugs for Malaria Market Competition, by Manufacturer

3.1 North America Drugs for Malaria Sales and Market Share by Manufacturer (2016-2017)

3.2 North America Drugs for Malaria Revenue and Market Share by Manufacturer (2016-2017)

3.3 North America Drugs for Malaria Price by Manufacturers (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Drugs for Malaria Manufacturer Market Share

3.4.2 Top 5 Drugs for Malaria Manufacturer Market Share

3.5 Market Competition Trend

4 North America Drugs for Malaria Market Analysis by Countries

4.1 North America Drugs for Malaria Sales Market Share by Countries

4.2 North America Drugs for Malaria Sales by Countries (2012-2017)

4.3 North America Drugs for Malaria Revenue (Value) by Countries (2012-2017)

5 North America Market Segmentation Drugs for Malaria by Type

5.1 North America Drugs for Malaria Sales, Revenue and Market Share by Type (2012-2017)

5.1.1 North America Drugs for Malaria Sales and Market Share by Type (2012-2017)

5.1.2 North America Drugs for Malaria Revenue and Market Share by Type (2012-2017)

5.2 Aryl Aminoalcohol Compounds Sales Growth and Price

5.2.1 North America Aryl Aminoalcohol Compounds Sales Growth (2012-2017)

5.2.2 North America Aryl Aminoalcohol Compounds Price (2012-2017)

5.3 Antifolate Compounds Sales Growth and Price

5.3.1 North America Antifolate Compounds Sales Growth (2012-2017)

5.3.2 North America Antifolate Compounds Price (2012-2017)

5.4 Artemisinin Compounds Sales Growth and Price

5.4.1 North America Artemisinin Compounds Sales Growth (2012-2017)

5.4.2 North America Artemisinin Compounds Price (2012-2017)

6 North America Market Segmentation Drugs for Malaria by Application

6.1 North America Drugs for Malaria Sales Market Share by Application (2012-2017)

6.2 Prevention Sales Growth (2012-2017)

6.3 Treatment Sales Growth (2012-2017)

6.4 Other Sales Growth (2012-2017)

7 United States Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers

7.1 United States Drugs for Malaria Revenue, Sales and Growth Rate (2012-2017)

7.2 United States Drugs for Malaria Sales and Market Share by Type

7.3 United States Drugs for Malaria Sales by Application (2012-2017)

7.4 United States Drugs for Malaria Sales, Revenue and Market Share by Manufacturer

7.4.1 United States Drugs for Malaria Sales and Market Share by Manufacturer

7.4.2 United States Drugs for Malaria Revenue and Market Share by Manufacturer

7.5 United States Drugs for Malaria Export and Import (2012-2017)

8 Canada Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers

8.1 Canada Drugs for Malaria Revenue, Sales and Growth Rate (2012-2017)

8.2 Canada Drugs for Malaria Sales and Market Share by Type

8.3 Canada Drugs for Malaria Sales by Application (2012-2017)

8.4 Canada Drugs for Malaria Sales, Revenue and Market Share by Manufacturer

8.4.1 Canada Drugs for Malaria Sales and Market Share by Manufacturer

8.4.2 Canada Drugs for Malaria Revenue and Market Share by Manufacturer

8.5 Canada Drugs for Malaria Export and Import (2012-2017)

9 Mexico Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers

9.1 Mexico Drugs for Malaria Revenue, Sales and Growth Rate (2012-2017)

9.2 Mexico Drugs for Malaria Sales and Market Share by Type

9.3 Mexico Drugs for Malaria Sales by Application (2012-2017)

9.4 Mexico Drugs for Malaria Sales, Revenue and Market Share by Manufacturer

9.4.1 Mexico Drugs for Malaria Sales and Market Share by Manufacturer

9.4.2 Mexico Drugs for Malaria Revenue and Market Share by Manufacturer

9.5 Mexico Drugs for Malaria Export and Import (2012-2017)

10 Drugs for Malaria Market Forecast (2017-2022)

10.1 North America Drugs for Malaria Sales, Revenue and Growth Rate (2017-2022)

10.2 Drugs for Malaria Market Forecast by Countries (2017-2022)

10.2.1 United States Drugs for Malaria Forecast (2017-2022)

10.2.2 Canada Drugs for Malaria Forecast (2017-2022)

10.2.3 Mexico Drugs for Malaria Forecast (2017-2022)

10.3 Drugs for Malaria Market Forecast by Type (2017-2022)

10.4 Drugs for Malaria Market Forecast by Application (2017-2022)

11 Drugs for Malaria Manufacturing Cost Analysis

11.1 Drugs for Malaria Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Drugs for Malaria

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Drugs for Malaria Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2016

12.4 Downstream Buyers

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Analyst Introduction

15.3 Data SourceList of Tables and Figures

Figure Drugs for Malaria Picture

Table Product Specifications of Drugs for Malaria

Figure North America Sales Market Share of Drugs for Malaria by Types in 2016

Table Types of Drugs for Malaria

Figure Aryl Aminoalcohol Compounds Picture

Table Major Manufacturers of Aryl Aminoalcohol Compounds

Figure Antifolate Compounds Picture

Table Major Manufacturers of Antifolate Compounds

Figure Artemisinin Compounds Picture

Table Major Manufacturers of Artemisinin Compounds

Table North America Drugs for Malaria Sales Market Share by Applications in 2016

Table Applications of Drugs for Malaria

Figure Prevention Picture

Figure Treatment Picture

Figure Other Picture

Figure United States Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)

Figure Mexico Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)

Figure Canada Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)

Table Cipla Basic Information, Manufacturing Base and Competitors

Table Cipla Drugs for Malaria Type and Applications

Table Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Guilin Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Guilin Pharmaceutical Drugs for Malaria Type and Applications

Table Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table IPCA Laboratories Basic Information, Manufacturing Base and Competitors

Table IPCA Laboratories Drugs for Malaria Type and Applications

Table IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Drugs for Malaria Type and Applications

Table GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Mylan Labs Basic Information, Manufacturing Base and Competitors

Table Mylan Labs Drugs for Malaria Type and Applications

Table Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Drugs for Malaria Type and Applications

Table Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Drugs for Malaria Type and Applications

Table Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Aventis Basic Information, Manufacturing Base and Competitors

Table Sanofi Aventis Drugs for Malaria Type and Applications

Table Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Ajanta Pharma Basic Information, Manufacturing Base and Competitors

Table Ajanta Pharma Drugs for Malaria Type and Applications

Table Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table North America Drugs for Malaria Sales by Manufacturer (2016-2017)

Figure North America Drugs for Malaria Sales Market Share by Manufacturer in 2016

Figure North America Drugs for Malaria Sales Market Share by Manufacturer in 2017

Table North America Drugs for Malaria Revenue by Manufacturer (2016-2017)

Figure North America Drugs for Malaria Revenue Market Share by Manufacturer in 2016

Figure North America Drugs for Malaria Revenue Market Share by Manufacturer in 2017

Table North America Drugs for Malaria Price by Manufacturers (2016-2017)

Figure Top 3 Drugs for Malaria Manufacturer Market Share in 2016

Figure Top 3 Drugs for Malaria Manufacturer Market Share in 2017

Figure Top 5 Drugs for Malaria Manufacturer Market Share in 2016

Figure Top 5 Drugs for Malaria Manufacturer Market Share in 2017

Figure North America Drugs for Malaria Sales and Growth (2012-2017)

Table North America Drugs for Malaria Sales by Countries (2012-2017)

Table North America Drugs for Malaria Sales Market Share by Countries (2012-2017)

Figure North America 2012 Drugs for Malaria Sales Market Share by Countries

Figure North America 2016 Drugs for Malaria Sales Market Share by Countries

Figure North America Drugs for Malaria Revenue and Growth (2012-2017)

Table North America Drugs for Malaria Revenue by Countries (2012-2017)

Table North America Drugs for Malaria Revenue Market Share by Countries (2012-2017)

Table North America 2012 Drugs for Malaria Revenue Market Share by Countries

Table North America 2016 Drugs for Malaria Revenue Market Share by Countries

Table North America Drugs for Malaria Sales by Type (2012-2017)

Table North America Drugs for Malaria Sales Share by Type (2012-2017)

Table North America Drugs for Malaria Revenue by Type (2012-2017)

Table North America Drugs for Malaria Revenue Share by Type (2012-2017)

Figure North America Aryl Aminoalcohol Compounds Sales Growth (2012-2017)

Figure North America Aryl Aminoalcohol Compounds Price (2012-2017)

Figure North America Antifolate Compounds Sales Growth (2012-2017)

Figure North America Antifolate Compounds Price (2012-2017)

Figure North America Artemisinin Compounds Sales Growth (2012-2017)

Figure North America Artemisinin Compounds Price (2012-2017)

Table North America Drugs for Malaria Sales by Application (2012-2017)

Table North America Drugs for Malaria Sales Share by Application (2012-2017)

Figure North America Prevention Sales Growth (2012-2017)

Figure North America Treatment Sales Growth (2012-2017)

Figure North America Other Sales Growth (2012-2017)

Figure United States Drugs for Malaria Revenue and Growth (2012-2017)

Figure United States Drugs for Malaria Sales and Growth (2012-2017)

Table United States Drugs for Malaria Sales by Type (2012-2017)

Table United States Drugs for Malaria Sales Market Share by Type (2012-2017)

Table United States Drugs for Malaria Sales by Application (2012-2017)

Table United States Drugs for Malaria Sales Market Share by Application (2012-2017)

Table United States Drugs for Malaria Sales by Manufacturer (2016-2017)

Figure United States Drugs for Malaria Sales Market Share by Manufacturer in 2016

Figure United States Drugs for Malaria Sales Market Share by Manufacturer in 2017

Table United States Drugs for Malaria Revenue by Manufacturer (2016-2017)

Figure United States Drugs for Malaria Revenue Market Share by Manufacturer in 2016

Figure United States Drugs for Malaria Revenue Market Share by Manufacturer in 2017

Table United States Drugs for Malaria Export and Import (2012-2017)

Figure Canada Drugs for Malaria Revenue and Growth (2012-2017)

Figure Canada Drugs for Malaria Sales and Growth (2012-2017)

Table Canada Drugs for Malaria Sales by Type (2012-2017)

Table Canada Drugs for Malaria Sales Market Share by Type (2012-2017)

Table Canada Drugs for Malaria Sales by Application (2012-2017)

Table Canada Drugs for Malaria Sales Market Share by Application (2012-2017)

Table Canada Drugs for Malaria Sales by Manufacturer (2016-2017)

Figure Canada Drugs for Malaria Sales Market Share by Manufacturer in 2016

Figure Canada Drugs for Malaria Sales Market Share by Manufacturer in 2017

Table Canada Drugs for Malaria Revenue by Manufacturer (2016-2017)

Figure Canada Drugs for Malaria Revenue Market Share by Manufacturer in 2016

Figure Canada Drugs for Malaria Revenue Market Share by Manufacturer in 2017

Table Canada Drugs for Malaria Export and Import (2012-2017)

Figure Mexico Drugs for Malaria Revenue and Growth (2012-2017)

Figure Mexico Drugs for Malaria Sales and Growth (2012-2017)

Table Mexico Drugs for Malaria Sales by Type (2012-2017)

Table Mexico Drugs for Malaria Sales Market Share by Type (2012-2017)

Table Mexico Drugs for Malaria Sales by Application (2012-2017)

Table Mexico Drugs for Malaria Sales Market Share by Application (2012-2017)

Table Mexico Drugs for Malaria Sales by Manufacturer (2016-2017)

Figure Mexico Drugs for Malaria Sales Market Share by Manufacturer in 2016

Figure Mexico Drugs for Malaria Sales Market Share by Manufacturer in 2017

Table Mexico Drugs for Malaria Revenue by Manufacturer (2016-2017)

Figure Mexico Drugs for Malaria Revenue Market Share by Manufacturer in 2016

Figure Mexico Drugs for Malaria Revenue Market Share by Manufacturer in 2017

Table Mexico Drugs for Malaria Export and Import (2012-2017)

Figure North America Drugs for Malaria Sales, Revenue and Growth Rate (2017-2022)

Table North America Drugs for Malaria Sales Forecast by Countries (2017-2022)

Table North America Drugs for Malaria Market Share Forecast by Countries (2017-2022)

Figure United States Drugs for Malaria Sales Forecast (2017-2022)

Figure Canada Drugs for Malaria Sales Forecast (2017-2022)

Figure Mexico Drugs for Malaria Sales Forecast (2017-2022)

Table North America Drugs for Malaria Sales Forecast by Type (2017-2022)

Table North America Drugs for Malaria Market Share Forecast by Type (2017-2022)

Table North America Drugs for Malaria Sales Forecast by Application (2017-2022)

Table North America Drugs for Malaria Market Share Forecast by Application (2017-2022)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Drugs for Malaria

Figure Manufacturing Process Analysis of Drugs for Malaria

Figure Drugs for Malaria Industrial Chain Analysis

Table Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2016

Table Major Buyers of Drugs for Malaria

Table Distributors/Traders/ Dealers List